Stephane Rooijen is the founder of Dynacure. Dynacure has raised $110M in total funding. Latest round: Series C. Based in Strasbourg, France.
Stephane van Rooijen is the CEO of Dynacure, a biotechnology company founded in 2016 that develops treatments for serious orphan disorders. Under his leadership, Dynacure raised significant funding to advance its lead program, DYN101, an antisense oligonucleotide therapy for centronuclear myopathy, into clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library